We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Efficient Drug Research with Tecan’s Freedom EVO® 75
Product News

Efficient Drug Research with Tecan’s Freedom EVO® 75

Efficient Drug Research with Tecan’s Freedom EVO® 75
Product News

Efficient Drug Research with Tecan’s Freedom EVO® 75


Want a FREE PDF version of This Product News?

Complete the form below and we will email you a PDF version of "Efficient Drug Research with Tecan’s Freedom EVO® 75"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

The pharmacokinetic testing laboratory at Toa Eiyo, a Japanese pharmaceutical company specializing in cardiovascular diseases, is using Tecan’s Freedom EVO 75 to achieve efficiency through automated sample preparation.

Dr Yoshiaki Watanabe, a chief research scientist at Toa Eiyo’s Fukushima Research Laboratories, explained: “Our section conducts pharmacokinetic, toxicity and safety testing on promising candidate compounds for drug development. We wanted to automate several sample preparation steps to achieve greater efficiency, and selected Tecan’s Freedom EVO 75 with an integrated 8 Plus 1 Access™ liquid handling arm for precision pipetting.”

“The characteristics of the Freedom EVO make it easy to use for many researchers. Even without specialist knowledge, it is very easy to write a script in the instrument’s operating software, Freedom EVOware®, or adapt existing programs with just a few changes. Installation of an automated pipetting device for pre-clinical and clinical testing has been very welcome, helping to reduce the burden of routine manual tasks, and we anticipate a far-reaching effect of its use in our future research themes.”
Advertisement